Hyperpolarized c-13 spectroscopic imaging of the TRAMP mouse at 3T - Initial experience

被引:167
作者
Chen, Albert P.
Albers, Mark J.
Cunningham, Charles H.
Kohler, Susan J.
Yen, Yi-Fen
Hurd, Ralph E.
Tropp, James
Bok, Robert
Pauly, John M.
Nelson, Sarah J.
Kurhanewicz, John
Vigneron, Daniel B.
机构
[1] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94158 USA
[2] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[4] GE Healthcare Technol, Menlo Pk, CA USA
[5] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA
关键词
DNP; C-13; TRAMP; MRSI; flyback; TO-NOISE RATIO; PROSTATE-CANCER; METABOLISM; DESIGN; H-1;
D O I
10.1002/mrm.21256
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The transgenic adenocarcinoma of mouse prostate (TRAMP) mouse is a well-studied murine model of prostate cancer with histopathology and disease progression that mimic the human disease. To investigate differences in cellular bioenergetics between normal prostate epithelial cells and prostate tumor cells, in vivo MR spectroscopic (MRS) studies with non-proton nuclei, such as C-13, in the TRAMP model would be extremely useful. The recent development of a method for retaining dynamic nuclear polarization (DNP) in solution permits high signal-to-noise ratio (SNR) C-13 MRI or MRSI data to be obtained following injection of a hyperpolarized C-13 agent. In this transgenic mouse study, this method was applied using a double spin-echo (DSE) pulse sequence with a small-tip-angle excitation RF pulse, hyperbolic-secant refocusing pulses, and a flyback echo-planar readout trajectory for fast (10-14 s) MRSI of C-13 pyruvate (pyr) and its metabolic products at 0.135 cm(3) nominal spatial resolution. Elevated C-13 lactate (lac) was observed in both primary and metastatic tumors, demonstrating the feasibility of studying cellular bioenergetics in vivo with DNP hyperpolarized C-13 MRSI.
引用
收藏
页码:1099 / 1106
页数:8
相关论文
共 27 条
[1]   Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR [J].
Ardenkjaer-Larsen, JH ;
Fridlund, B ;
Gram, A ;
Hansson, G ;
Hansson, L ;
Lerche, MH ;
Servin, R ;
Thaning, M ;
Golman, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) :10158-10163
[2]   Magnetic resonance imaging and spectroscopic imaging of prostate cancer [J].
Coakley, FV ;
Qayyum, A ;
Kurhanewicz, J .
JOURNAL OF UROLOGY, 2003, 170 (06) :S69-S75
[3]   A REDUCED POWER SELECTIVE ADIABATIC SPIN-ECHO PULSE SEQUENCE [J].
CONOLLY, S ;
GLOVER, G ;
NISHIMURA, D ;
MACOVSKI, A .
MAGNETIC RESONANCE IN MEDICINE, 1991, 18 (01) :28-38
[4]   CHARACTERIZATION OF HUMAN PROSTATE-CANCER, BENIGN PROSTATIC HYPERPLASIA AND NORMAL PROSTATE BY IN-VITRO H-1 AND P-31 MAGNETIC-RESONANCE SPECTROSCOPY [J].
CORNEL, EB ;
SMITS, GAHJ ;
OOSTERHOF, GON ;
KARTHAUS, HFM ;
DEBRUYNE, FMJ ;
SCHALKEN, JA ;
HEERSCHAP, A .
JOURNAL OF UROLOGY, 1993, 150 (06) :2019-2024
[5]  
Costello LC, 1998, PROSTATE, V35, P285, DOI 10.1002/(SICI)1097-0045(19980601)35:4<285::AID-PROS8>3.0.CO
[6]  
2-F
[7]   BIOENERGETIC THEORY OF PROSTATE MALIGNANCY [J].
COSTELLO, LC ;
FRANKLIN, RB .
PROSTATE, 1994, 25 (03) :162-166
[8]   Design of flyback echo-planar readout gradients for magnetic resonance spectroscopic imaging [J].
Cunningham, CH ;
Vigneron, DB ;
Chen, AP ;
Xu, D ;
Nelson, SJ ;
Hurd, RE ;
Kelley, DA ;
Pauly, JM .
MAGNETIC RESONANCE IN MEDICINE, 2005, 54 (05) :1286-1289
[9]   DESIGN AND EVALUATION OF A NOVEL DUAL-TUNED RESONATOR FOR SPECTROSCOPIC IMAGING [J].
DERBY, K ;
TROPP, J ;
HAWRYSZKO, C .
JOURNAL OF MAGNETIC RESONANCE, 1990, 86 (03) :645-651
[10]  
Dreher W, 2000, MAGN RESON MED, V44, P668, DOI 10.1002/1522-2594(200011)44:5<668::AID-MRM2>3.0.CO